Results 181 to 190 of about 641,965 (301)

Visual Patterns of Diaphragmatic Motion in Acute Respiratory Failure: A Prospective Pilot Study

open access: yesJournal of Clinical Ultrasound, Volume 53, Issue 3, Page 421-428, March/April 2025.
In this prospective bicentric study, we studied the relationship between the appearance of diaphragmatic motion and the etiological diagnosis of patients admitted to the emergency department with ARF. We observed a different visual pattern in patients with pneumonia. This is an interesting result as it allows the diagnosis of pneumonia without the need
Thibaut Markarian   +7 more
wiley   +1 more source

Algorithm-based assessment of T-cell dysfunction and exclusion to forecast ICB sensitivity in pediatric brain ependymoma. [PDF]

open access: yesJ Neurooncol
Palermo M   +6 more
europepmc   +1 more source

Trajectory of irritability in children and youth in Ontario, Canada, throughout the COVID‐19 pandemic

open access: yesJCPP Advances, EarlyView.
This study explored how irritability in children and youth changed during the COVID‐19 pandemic and its impact on mental health. Results showed a gradual decline in irritability, with factors like age, parental anxiety, and resilience influencing its trajectory.
Theodore C. K. Cheung   +12 more
wiley   +1 more source

A web of tidings [PDF]

open access: yesNature Machine Intelligence, 2019
openaire   +1 more source

Comparison of Single‐Breath and Multi‐Breath Xe‐MRI in the Longitudinal Assessment of Treatment in Children With Cystic Fibrosis

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Elexacaftor/tezacaftor/ivacaftor (ETI) is a current standard therapy for pediatric cystic fibrosis (CF). Multiple‐breath washout 129Xe MRI (MBW Xe‐MRI) is improved following 1 month of treatment. However, the utility of MBW Xe‐MRI over extended ETI treatment and its comparison to single‐breath Xe‐MRI and pulmonary function tests ...
Faiyza S. Alam   +6 more
wiley   +1 more source

Exosome-like nanovesicles from acerola for CRISPR-Cas9 ribonucleoprotein delivery to the central nervous system. [PDF]

open access: yesMol Ther Nucleic Acids
Nagamatsu Y   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy